<i>In vitro</i> cell model to dilucidate the underlying molecular mechanism associated with ophthalmic manifestation of congenital disorders of glycosylation: studying an ALG2-CDG patient. [PDF]
Cubilla MA +3 more
europepmc +1 more source
Outcome of creatine supplementation therapy in phosphoglucomutase-1 deficiency associated congenital disorders of glycosylation: Novel insights. [PDF]
Ambrose A +5 more
europepmc +1 more source
Congenital disorders of glycosylation type 1A associated with cerebral hemorrhagic infarction: illustrative case. [PDF]
Nomura Y +6 more
europepmc +1 more source
Clinical and biochemical footprints of congenital disorders of glycosylation: Proposed nosology. [PDF]
Ng BG +4 more
europepmc +1 more source
Mapping the diagnostic odyssey of congenital disorders of glycosylation (CDG): insights from the community. [PDF]
Granjo P +10 more
europepmc +1 more source
Genetic counseling for congenital disorders of glycosylation (CDG). [PDF]
Weixel T, Wolfe L, Macnamara EF.
europepmc +1 more source
Cardiomyopathy, an uncommon phenotype of congenital disorders of glycosylation: Recommendations for baseline screening and follow-up evaluation. [PDF]
Zemet R +11 more
europepmc +1 more source
Congenital disorders of glycosylation with multiorgan disruption and immune dysregulation caused by compound heterozygous variants in MAN2B2. [PDF]
Fan S, Wu H, Wang R, Chen Q, Zhang X.
europepmc +1 more source
Frontiers in congenital disorders of glycosylation consortium, a cross-sectional study report at year 5 of 280 individuals in the natural history cohort. [PDF]
Lam C +51 more
europepmc +1 more source
Liposome-encapsulated mannose-1-phosphate therapy improves global N-glycosylation in different congenital disorders of glycosylation. [PDF]
Budhraja R +7 more
europepmc +1 more source

